A highly predictive autoantibody-based biomarker panel for prognosis in early-stage NSCLC with potential therapeutic implications

BACKGROUND: Lung cancer is the leading cause of cancer-related death worldwide. Surgical resection remains the definitive curative treatment for early-stage disease offering an overall 5-year survival rate of 62%. Despite careful case selection, a significant proportion of early-stage cancers relaps...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Akshay J., Tan, Ti-Myen, Richter, Alex G., Naidu, Babu, Blackburn, Jonathan M., Middleton, Gary W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770460/
https://www.ncbi.nlm.nih.gov/pubmed/34728792
http://dx.doi.org/10.1038/s41416-021-01572-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770460/
https://www.ncbi.nlm.nih.gov/pubmed/34728792
http://dx.doi.org/10.1038/s41416-021-01572-x

Ejemplares similares